Renal metastasis refers to hematogenous spread of a primary malignancy from another organ to the kidney. The most common primary sites are lung carcinoma, breast carcinoma, and melanoma; less frequently colorectal, ovarian, gastric, and other primary tumors may metastasize to the kidneys. Renal metastases are typically bilateral and multifocal, cortically located, and usually present as small (<3 cm) lesions. Most metastases are hypovascular and show poor enhancement after contrast administration; however, melanoma, thyroid carcinoma, and renal cell carcinoma metastases can be hypervascular. Renal metastases are frequently asymptomatic and are incidentally detected on staging CT of the primary tumor. Rarely, they may present with hematuria or renal insufficiency. Autopsy series have demonstrated renal metastases in 7-13% of patients with advanced cancer, a rate significantly higher than clinically detected.
Age Range
40-80
Peak Age
65
Gender
Equal
Prevalence
Uncommon
Renal metastases develop through three main mechanisms: (1) Hematogenous spread — the most common pathway, where tumor cells enter the systemic circulation after the primary tumor invades the arterial or venous system, reaching the kidney via renal arteries. The kidneys receive approximately 20-25% of cardiac output, and this high blood flow increases the probability of metastatic seeding. (2) Lymphatic spread — metastatic disease in retroperitoneal lymph nodes can extend to the kidney through perinephric lymphatics. (3) Direct invasion — tumors from adjacent organs (adrenal carcinoma, retroperitoneal sarcoma) may involve the kidney through direct extension across Gerota fascia. Metastatic lesions are typically cortically located because the renal cortex receives the majority of renal blood flow (interlobar arteries → arcuate arteries → interlobular arteries → afferent arterioles). Most metastases demonstrate low neoangiogenesis and are therefore hypovascular; however, primarily hypervascular tumors such as melanoma and thyroid carcinoma produce hypervascular metastases in the kidney as well. Bilateral involvement reflects the systemic nature of metastatic disease and is generally accompanied by widespread metastatic burden.
Detection of bilateral, multifocal, small (<3 cm), hypodense, cortically located solid lesions against homogeneously enhancing renal parenchyma in the nephrographic phase in a patient with known primary malignancy history is the strongest and most commonly encountered finding for renal metastasis. This pattern differs from primary RCC (typically solitary, large, heterogeneous) and lymphoma (hypoenhancing, generally larger, may have perinephric involvement). The triad of bilateral involvement + known malignancy + small size significantly increases diagnostic probability.
On non-contrast CT, bilateral, multifocal, small (usually <3 cm), solid, homogeneous soft tissue density cortical lesions are seen. The lesions are isodense or mildly hypodense relative to the renal parenchyma. Calcification is typically absent (except post-treatment). Fat content is not expected. Bilateral involvement is characteristic of metastatic disease and differs from primary RCC (typically solitary, large, heterogeneous). The perinephric Gerota fascia is usually intact.
Report Sentence
Bilateral, cortically located, multifocal, small, homogeneous soft tissue density solid lesions are seen in both kidneys, compatible with metastatic disease in the context of known primary malignancy.
In the corticomedullary phase, the majority of renal metastases remain distinctly hypodense against the intensely enhancing normal renal cortex. This hypovascular pattern is typical for metastases from the most common primary tumors such as lung, breast, colorectal, and gastric. The lesions show homogeneously poor enhancement and differ from the heterogeneous, intense arterial enhancement of RCC. However, melanoma, thyroid carcinoma, and carcinoid tumor metastases can be hypervascular and show intense enhancement in the corticomedullary phase — this may mimic primary RCC.
Report Sentence
In the corticomedullary phase, renal lesions remain distinctly hypodense against the intensely enhancing normal renal cortex, demonstrating an enhancement pattern consistent with hypovascular metastatic disease.
The nephrographic phase (80-180 seconds) is the most sensitive phase for detecting renal metastases. In this phase, normal renal parenchyma enhances homogeneously and intensely, allowing optimal delineation of small hypodense metastatic lesions. Hypovascular metastases remain distinctly hypodense. Lesion margins are more clearly defined in this phase. Multiple small lesions are best detected in this phase — some may be missed on the corticomedullary phase. Lesion count and distribution pattern (cortical predominance, bilateral) are best evaluated in this phase.
Report Sentence
In the nephrographic phase, multiple hypodense cortical lesions are more conspicuously delineated against the homogeneously enhancing normal renal parenchyma, consistent with metastatic disease.
On T2-weighted MR images, renal metastases typically show mildly to moderately hyperintense signal relative to normal renal parenchyma. Homogeneous signal intensity is characteristic and differs from the heterogeneous T2 signal of primary RCC. Melanoma metastases are an exception — they may be hypointense or isointense on T2 due to melanin content. Metastases with coagulative necrosis (especially larger lesions) may show central T2 hyperintensity. Peritumoral edema is generally not prominent — unlike RCC, aggressive local invasion is not expected. Bilateral and multifocal distribution is easily assessed on T2.
Report Sentence
On T2-weighted sequences, multifocal solid lesions with mildly hyperintense signal are seen in both kidneys at cortical locations, with a homogeneous signal pattern consistent with metastatic disease.
On T1-weighted MR images, melanoma metastases typically show hyperintense signal — this is due to melanin content and/or intralesional hemorrhage. Melanotic melanoma metastases demonstrate marked T1 hyperintensity and can almost always be distinguished from other metastasis types. Amelanotic melanoma metastases may not show T1 hyperintensity and can be confused with other metastasis types in this case. Metastases other than melanoma generally show isointense or mildly hypointense signal on T1. Hemorrhagic metastases (especially thyroid and choriocarcinoma-derived) can also show T1 hyperintensity. T1-hyperintense renal lesion combined with known melanoma history is pathognomonic for diagnosis.
Report Sentence
On T1-weighted sequences, a cortical lesion with markedly hyperintense signal is seen in the upper pole of the left kidney, consistent with melanin-containing metastasis in the context of known melanoma history.
On diffusion-weighted imaging (DWI), renal metastases typically show diffusion restriction — hyperintense signal on high b-values (b=800-1000) and low signal on ADC maps. Diffusion restriction reflects the high cellularity of metastatic lesions. DWI is particularly valuable for metastasis detection in patients who cannot receive contrast (renal insufficiency). Small cortical lesions that may be missed on standard T2 or T1 sequences are easily detected on DWI. ADC values are generally in the range of 0.8-1.2 × 10⁻³ mm²/s, supporting malignant character.
Report Sentence
On diffusion-weighted imaging, bilateral renal lesions demonstrate marked diffusion restriction (ADC: 1.0 × 10⁻³ mm²/s), consistent with high cellularity and supportive of metastatic disease.
On B-mode ultrasonography, renal metastases generally appear as small, hypoechoic, solid, cortically located lesions. The lesions have homogeneous echotexture and are hypoechoic relative to surrounding renal parenchyma. Bilateral and multifocal distribution is assessed by US but detection of small lesions (<1 cm) is limited. Melanoma metastases may be hyperechoic — melanin content and hemorrhage tendency increase acoustic impedance differences. Some metastases may be isoechoic and difficult to distinguish from normal parenchyma. US has lower sensitivity than CT and MR for renal metastasis detection and is not recommended as a primary screening method.
Report Sentence
On B-mode ultrasonography, small, hypoechoic, solid, cortically located lesions are seen in both kidneys; in the context of known malignancy, advanced imaging (CT/MR) is recommended for metastatic disease evaluation.
On FDG PET-CT, renal metastases generally show increased FDG uptake. Normal renal parenchyma demonstrates intense activity due to high physiological FDG excretion, which complicates detection of small cortical metastases. However, multifocal, focally increased renal foci — especially in the context of known primary malignancy — are consistent with metastatic disease. SUVmax generally depends on primary tumor type; melanoma and lung carcinoma metastases show high FDG avidity, while low-grade tumors may demonstrate lower uptake. The greatest advantage of PET-CT is simultaneous evaluation of concurrent metastatic foci in other organs.
Report Sentence
On FDG PET-CT, multifocal foci of focally increased metabolic activity are seen in both kidneys (SUVmax: 5.2), consistent with widespread metastatic disease in conjunction with metastatic foci in other organs.
Criteria
Solid lesion showing poor enhancement after contrast, remaining hypodense relative to normal renal parenchyma. Distinct hypodensity in corticomedullary and nephrographic phases. Most commonly originates from lung carcinoma, breast carcinoma, colorectal carcinoma, and gastric carcinoma.
Distinct Features
Low neoangiogenesis, homogeneous poor enhancement, marked corticomedullary-lesion contrast difference. Best detected on CT in nephrographic phase. On MR: T1 isointense/hypointense, T2 mildly hyperintense. Difference from lymphoma: generally smaller, perinephric involvement rare, retroperitoneal lymphadenopathy not mandatory.
Criteria
Solid lesion showing intense arterial enhancement in the corticomedullary phase. May show washout or isodensity in portal venous/nephrographic phases. Most commonly originates from melanoma, thyroid carcinoma, renal cell carcinoma (contralateral kidney metastasis), carcinoid tumor, and choriocarcinoma.
Distinct Features
May mimic primary RCC — the most challenging situation in differential diagnosis. T1 hyperintensity (melanin) is pathognomonic in melanoma. In thyroid-derived metastases, known thyroid carcinoma history and elevated thyroglobulin are guiding. Contralateral kidney metastasis is evaluated in conjunction with ipsilateral nephrectomy history. Multifocality and bilaterality are important distinguishing criteria from primary RCC.
Criteria
Metastasis containing intralesional hemorrhage. High density on non-contrast CT (>50 HU), T1 hyperintensity on MR (methemoglobin), heterogeneous signal on T2. Most commonly originates from melanoma, choriocarcinoma, thyroid carcinoma, and lung carcinoma. May present with spontaneous perinephric hematoma (Wunderlich syndrome).
Distinct Features
Hyperdense appearance on non-contrast CT differs from simple cyst or lymphoma. Susceptibility artifact (blooming) on gradient echo (T2*) sequences indicates hemosiderin deposition. The combination of melanoma + T1 hyperintensity + hemorrhage is diagnostically conclusive. Metastases causing spontaneous perinephric hematoma may require emergency surgery or embolization. Difference from AML: fat content not expected, known malignancy history is present.
Criteria
Metastasis diffusely infiltrating renal parenchyma or extending into the perinephric space without forming a focal mass. Irregularity of kidney contour, perinephric fat infiltration, and thickening of Gerota fascia are seen. Renal function loss and hydronephrosis may accompany. Most commonly originates from lymphoma, lung, and breast carcinoma.
Distinct Features
Differentiation from lymphoma is challenging — the perinephric rind pattern is more characteristic of lymphoma. Infiltrative metastasis can be confused with retroperitoneal fibrosis and xanthogranulomatous pyelonephritis in the differential diagnosis. Clinical context (known malignancy history, other metastatic foci) and biopsy are guiding in diagnosis. Bilateral infiltrative involvement indicates advanced metastatic disease.
Distinguishing Feature
Renal lymphoma typically forms larger, homogeneously hypoenhancing masses and shows prominent perinephric soft tissue infiltration (rind pattern) — this pattern is rare in metastasis. Retroperitoneal lymphadenopathy is almost always present in lymphoma and masses are generally solitary or few in number. Metastases are generally smaller, multifocal, and cortically located. Renal sinus invasion and nephromegaly are more prominent in lymphoma.
Distinguishing Feature
Clear cell RCC is typically a solitary, large (>4 cm), heterogeneous mass showing intense arterial enhancement in the corticomedullary phase + washout in the nephrographic phase. Necrosis, hemorrhage, and cystic change are common. Renal vein thrombosis and renal sinus invasion are prominent in RCC but rare in metastasis. Metastases are generally small (<3 cm), multifocal, and bilateral — RCC is usually solitary and unilateral. Known primary malignancy history is the strongest clinical differentiator favoring metastasis.
Distinguishing Feature
Renal infarct is typically wedge-shaped (base facing the capsule), extending from cortex to medulla, showing non-enhancement after contrast. The cortical rim sign (a thin rim of cortical enhancement due to capsular collateral vessels) is characteristic of infarct. Metastases are round or oval in shape and do not show wedge morphology. Infarct usually accompanies acute clinical presentation (flank pain, hematuria) and an embolic source such as atrial fibrillation or endocarditis is present. Chronic infarct scarring shows focal cortical retraction — not expected in metastasis.
Distinguishing Feature
Renal abscess is a centrally hypodense/necrotic collection showing rim enhancement (thick, irregular wall). Peripheral edema and perinephric fluid/fat stranding accompany. Clinically, fever, leukocytosis, and flank pain are present — these findings are not expected in metastasis. Abscess is usually solitary and unilateral. Gas bubbles may be seen within the abscess — not expected in metastasis. Abscess content shows marked diffusion restriction on DWI (viscous pus). Central liquefied collection is not expected in metastasis and the clinical picture differs.
Urgency
urgentManagement
medicalBiopsy
NeededFollow-up
specialist-referralDetection of renal metastasis signifies advanced stage (Stage IV) metastatic disease and directly affects treatment strategy. Management depends on the primary tumor type, extent of other metastatic foci, and the patient's overall condition. In most cases, systemic chemotherapy or targeted therapy (including immunotherapy) is the primary treatment option. Biopsy is recommended when the primary tumor is unknown or histological confirmation is needed (if it would change treatment planning); if a known primary malignancy and typical appearance are present, biopsy is not mandatory. Surgical resection is rarely indicated — nephron-sparing surgery may be considered only for solitary renal metastasis with controlled primary disease. Oncology consultation is mandatory. Follow-up should include regular imaging (typically CT every 2-3 months) to assess treatment response.
The presence of renal metastases indicates widespread metastatic disease and poor prognosis. Treatment depends on systemic oncological approach. In rare cases, surgical resection of solitary metastasis may be considered.